Forward Pharma A/S reported unaudited consolidated earnings results for the six months ended June 30, 2018. For the six months, the company reported operating loss of $7,646,000 against income of $1,213,594,000 reported a year ago. Loss before taxes was $5,474,000 against income of $1,213,010,000 reported a year ago. Net loss was $5,270,000 or $0.06 per diluted share against income of $941,236,000 or $1.67 per diluted share reported a year ago. Net cash used in provided by operating activities was $10,115,000 against net cash flows provided by operating activities of $1,211,049,000 reported a year ago.